Kesselheim AS - Search Results

1

Changes in Price for Generic Drugs in the USA, 2008-2016.

Dave CV, Brill G, Kesselheim AS. Dave CV, et al. Among authors: kesselheim as. J Gen Intern Med. 2019 Sep;34(9):1677-1679. doi: 10.1007/s11606-019-05033-3. J Gen Intern Med. 2019. PMID: 31065948 Free PMC article. No abstract available.

2

Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending.

Kesselheim AS, Fischer MA, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2006 Nov-Dec;25(6):1637-47. doi: 10.1377/hlthaff.25.6.1637. Health Aff (Millwood). 2006. PMID: 17102189

3

Whistleblower-initiated enforcement actions against health care fraud and abuse in the United States, 1996 to 2005.

Kesselheim AS, Studdert DM. Kesselheim AS, et al. Ann Intern Med. 2008 Sep 2;149(5):342-9. doi: 10.7326/0003-4819-149-5-200809020-00009. Ann Intern Med. 2008. PMID: 18765704

4

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH. Kesselheim AS, et al. JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758. JAMA. 2008. PMID: 19050195 Free PMC article. Review.

5

Risk, responsibility, and generic drugs.

Kesselheim AS, Avorn J, Greene JA. Kesselheim AS, et al. N Engl J Med. 2012 Nov 1;367(18):1679-81. doi: 10.1056/NEJMp1208781. N Engl J Med. 2012. PMID: 23113477 Free PMC article. No abstract available.

6

Changing interactions between physician trainees and the pharmaceutical industry: a national survey.

Austad KE, Avorn J, Franklin JM, Kowal MK, Campbell EG, Kesselheim AS. Austad KE, et al. Among authors: kesselheim as. J Gen Intern Med. 2013 Aug;28(8):1064-71. doi: 10.1007/s11606-013-2361-0. J Gen Intern Med. 2013. PMID: 23444007 Free PMC article. Clinical Trial.

7

Who is now responsible for discovering and warning about adverse effects of generic drugs?

Kesselheim AS, Green MD, Avorn J. Kesselheim AS, et al. JAMA. 2013 Sep 11;310(10):1023-4. doi: 10.1001/jama.2013.228349. JAMA. 2013. PMID: 23922000 No abstract available.

8

Patterns and predictors of generic narrow therapeutic index drug use among older adults.

Gagne JJ, Polinski JM, Kesselheim AS, Choudhry NK, Hutchins D, Matlin OS, Tong A, Shrank WH. Gagne JJ, et al. Among authors: kesselheim as. J Am Geriatr Soc. 2013 Sep;61(9):1586-91. doi: 10.1111/jgs.12399. Epub 2013 Sep 3. J Am Geriatr Soc. 2013. PMID: 24001285

9

The Food and Drug Administration's role in promoting consistent labels for generic drugs.

Duke JD, Kesselheim AS. Duke JD, et al. Among authors: kesselheim as. JAMA Intern Med. 2014 Aug;174(8):1213-4. doi: 10.1001/jamainternmed.2014.2705. JAMA Intern Med. 2014. PMID: 24957047 No abstract available.

10

Chemotherapy parity laws: a remedy for high drug costs?

Wang B, Joffe S, Kesselheim AS. Wang B, et al. Among authors: kesselheim as. JAMA Intern Med. 2014 Nov;174(11):1721-2. doi: 10.1001/jamainternmed.2014.4878. JAMA Intern Med. 2014. PMID: 25243936 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

708 results

Search Page